Clinical Trial Update: Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome. [Phase 3]

View source ↗

Summary

A long-term Phase 3 study comparing gabapentin enacarbil to placebo in patients with Restless Legs Syndrome has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: XenoPort, Inc. | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2011-05-25